Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Clinical trial NCT00320398 · COMPLETED

Trial details

NCT number: NCT00320398
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombosis, Venous

Start date: 2006-01-30
Primary completion: 2006-07-18
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.